A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
Applying to 31791, Whitman-Walker Institute, Inc. CRS · Washington D.C., District of Columbia
Answer a few short questions to share with the research team.